Navigation Links
Deadly fish virus now found in all Great Lakes
Date:1/27/2010

ITHACA, N.Y. A deadly fish virus that was first discovered in the Northeast in 2005 has been found for the first time in fish from Lake Superior, report Cornell researchers. That means that the virus has now been documented in all of the Great Lakes.

The viral hemorrhagic septicemia virus (VHSV), which causes fatal anemia and hemorrhaging in many fish species, poses no threat to humans, said Paul Bowser, professor of aquatic animal medicine at Cornell's College of Veterinary Medicine.

Bowser and colleagues recently tested 874 fish from seven sites in Lake Superior in collaboration with the U.S. Geological Survey (USGS) Western Fisheries Research Center in Seattle. Fish from Paradise and Skanee in Michigan and St. Louis Bay and Superior Bay in Wisconsin tested positive. Some of the results have been corroborated by other laboratories; others have tests still under way.

The virus, which has been identified in 28 freshwater fish species in the Great Lakes watershed, has reached epidemic proportions in the Great Lakes and threatens New York's sport-fishing industry, said Bowser, estimated to contribute some $1.4 billion annually to New York's economy.

"People come from all over the eastern United States to fish the Great Lakes," said Bowser, noting that the virus has also been found in a few inland waters as well, including lakes, streams and a family-owned earthen pond.

"The economy of many of these areas ebbs and flows with the season and perceived value of outdoor recreational opportunities. The value of these opportunities is dependent on how successful we are at managing the health of wild fish. On a worldwide basis, VHSV is considered one of the most serious pathogens of fish, because it kills so many fish, is not treatable and infects a broad range of fish species."

In 2008 the U.S. Department of Agriculture issued a federal order preventing transport of the 28 species within the Great Lakes watershed, including Lake Superior, to limit the spread of this viral pathogen. As a result, the new findings will not lead to additional regulatory actions, according to authorities.

While no significant fish mortality due to VHSV was observed in 2008 and 2009, "It is important to note that there are still fish harboring VHSV; essentially the infection proceeds even though no mortalities are being observed," said Bowser. "This is important because it suggests that these infected fish may serve as a reservoir for the virus in the Great Lakes ecosystem. While we don't fully understand the lack of recent mortality, the potential presence or absence of stressors on the fish may be playing a role."


'/>"/>

Contact: Joe Schwartz
bjs54@cornell.edu
607-254-6235
Cornell University
Source:Eurekalert

Related biology news :

1. Disarming specialized stem cells might combat deadly ovarian cancer
2. Iowa State University researcher discovers Ebolas deadly secret
3. A deadly scorpion provides a safe pesticide
4. U of Alberta researchers find mechanism that could prevent or treat deadly peroxisome diseases
5. A trip to the candy store might help ward off rare, but deadly infections
6. New compounds may control deadly fungal infections
7. Compound found to safely counter deadly bird flu
8. USU scientists report major advance in human antibody therapy against deadly Nipah virus
9. Satellite data look behind the scenes of deadly earthquake
10. New hope for deadly childhood bone cancer
11. Komodo even more deadly than thought: Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology: